
|Articles|November 8, 2018
Vivozon’s Non-Opioid PainKiller Has Been Granted the FDA’s Fast Track Designation
Advertisement
MMS Holdings Inc., a data-focused CRO, announced that the company has assisted Korea-based Vivozon Inc. in achieving a Fast Track Designation from the Food and Drug Administration for VVZ-149, a non-opioid painkiller. Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Clinical Trials in 2026: Platformization, AI Fluency, and the Redrawing of the Value Chain
2
FDA Issues Draft Guidance to Advance Bayesian Methods in Clinical Trials
3
Breaking Out of AI Pilot Mode in Clinical Development
4
ACT Brief: Community Sites Prove Readiness, Platformization Reshapes Clinical Ops, and AI Targets Precision Care at JPM
5



